Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.0B | 5.7B | 4.6B | 4.4B |
Cost of revenue | 2.7B | 3.1B | 2.9B | 2.8B |
Gross profit | 2.3B | 2.6B | 1.7B | 1.6B |
Operating expense | ||||
Research & development | 43M | 48M | 47M | 49M |
Selling general and admin | 110M | 128M | 113M | 100M |
Other operating expenses | 142M | 86M | 206M | 151M |
Operating income | 2.0B | 2.3B | 1.3B | 1.3B |
Non operating interest income | ||||
Income | 41M | 38M | 37M | 38M |
Expense | 79M | 93M | 86M | 103M |
Other income expense | 493M | -201M | -190M | -243M |
Pretax income | 2.5B | 2.1B | 1.1B | 1.0B |
Tax provision | 647M | 702M | 244M | 191M |
Net income | 1.9B | 1.4B | 924M | 857M |
Basic EPS | 1.7 | 1.2 | 0.8 | 0.7 |
Diluted EPS | 1.7 | 1.2 | 0.8 | 0.7 |
Basic average shares | 1.1B | 1.1B | 1.1B | 1.2B |
Diluted average shares | 1.1B | 1.1B | 1.1B | 1.2B |
EBITDA | 2.6B | 3.0B | 2.0B | 2.0B |
Net income from continuing op. | 1.9B | 1.4B | 924M | 857M |
Minority interests | -11M | -18M | -2M | -4M |
Preferred stock dividends | — | — | — | — |